
FDA DRAFT GUIDANCE: Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies Guidance for Industry
In recent years, the US Congress and the US Food and Drug Administration (FDA) have emphasized the importance of including underrepresented populations in clinical trials. This push for diversity is not just a regulatory requirement but a critical step towards … Read More

Charting New Horizons for Clinical Trials: InSilicoTrials at DIA 2024
InSilicoTrials recently participated in the DIA 2024 Global Annual Meeting, (16-20 June, San Diego), sharing valuable insights on the use of in silico trials, digital twins, and AI-powered predictive intelligence in drug development and patient care. This event provided a … Read More

FDA releases guidance for dose optimization in oncology trials
Following the 2021 launch of Project Optimus by the Oncology Center of Excellence and an extensive workshop on the topic, in January 2023 the FDA released a draft guidance for industry entitled “Optimizing the Dosage of Human Prescription Drugs and … Read More

Successes and Opportunities in Modeling & Simulation for FDA
The use of in silico trials is expected to play an increasingly important role in the development and regulatory evaluation of new drugs and medical devices. One of the advantages that in silico approaches offer is the possibility to test … Read More

An interview with Manuel Ottaviano
Manuel Ottaviano has a M.Sc. Computer Science Engineering and a PhD in Bioengineering. He works as senior researcher in digital health and wellbeing at the University of Madrid UPM. He studies human factors implied in the design of digital technologies for health. He explores different … Read More

An interview with Prof. Christine Le Maitre
Our conversations on in silico methods in medicine are becoming more and more interesting. Christine Le Maitre, Professor of Cell Biology and Tissue Regeneration at Sheffield Hallam University, England, is the Head of the Tissue Engineering and Biomechanics Research Group … Read More

An interview with Prof. Mariano Vázquez
Modeling the human body is certainly one of the most extraordinary applications of computational simulation. We talked about this with Mariano Vázquez, a PhD in Physics, currently CTO/CSO at ELEM Biotech, a spinoff company of the Barcelona Supercomputing Center (BSC), … Read More
Simulation to help fight cardiovascular disease
Simulation to help fight cardiovascular disease. As we all know, cardiovascular disease (CVD) is the leading cause of death worldwide, with 18 million deaths each year according to WHO estimates. Currently, 15 million people in Europe live with heart failure. You can see why we were so … Read More

An interview with Prof. Javier Saiz
We met Javier Saiz – Professor of Biomedical Engineering at the Polytechnic University of Valencia, Spain – who led the research group that created the computational model which is at the core of our QT/TdP Risk Screen product, available on our cloud-based platform. Our objective was to … Read More

An interview with Prof. Stefano Severi
We met Stefano Severi – Assistant Professor of Biomedical Engineering department of Electronics, Computer Science and Systems of the University of Bologna, Italy – who created a computational model which is at the core of STrhiPS: a web-based tool that helps perform in … Read More